In summary, our findings demonstrate that Alpinetin alleviates MPTP‐induced tyrosine hydroxylase‐positive (TH+) neuronal loss and DA damage, improving PD‐related symptoms by mitigating motor deficits, increasing DA neuron populations, and reducing mitophagy impairment. The gene discussed is TH; the disease is Parkinson disease.